It was believed that AEL could be distinguished by cytogenetic and molecular genetic characteristics, such as RUNX1 and TP53 mutations that implied the worse outcome and NPM1 mutation that implied better outcome [7]. The gene discussed is TP53; the disease is acute erythroid leukemia.